Your browser doesn't support javascript.
Reduced levels of pulmonary surfactant in COVID-19 ARDS.
Schousboe, Peter; Ronit, Andreas; Nielsen, Henning B; Benfield, Thomas; Wiese, Lothar; Scoutaris, Nikolaos; Verder, Henrik; Berg, Ronan M G; Verder, Povl; Plovsing, Ronni R.
  • Schousboe P; Pediatric Research Unit, Department of Pediatrics, Holbaek University Hospital, 4300, Holbaek, Denmark. petsc@regionsjaelland.dk.
  • Ronit A; Department of Infectious Diseases, Hvidovre Hospital, University of Copenhagen, Copenhagen, Denmark. andreas.ronit.01@regionh.dk.
  • Nielsen HB; Department of Anesthesia and Intensive Care, Zealand University Hospital Roskilde, Copenhagen, Denmark.
  • Benfield T; Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.
  • Wiese L; Department of Infectious Diseases, Hvidovre Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Scoutaris N; Department of Infectious Diseases, Zealand University Hospital, Roskilde, Denmark.
  • Verder H; Pediatric Research Unit, Department of Pediatrics, Holbaek University Hospital, 4300, Holbaek, Denmark.
  • Berg RMG; Pediatric Research Unit, Department of Pediatrics, Holbaek University Hospital, 4300, Holbaek, Denmark.
  • Verder P; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Plovsing RR; Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet University, Copenhagen, Denmark.
Sci Rep ; 12(1): 4040, 2022 03 08.
Article in English | MEDLINE | ID: covidwho-1908245
ABSTRACT
To provide novel data on surfactant levels in adult COVID-19 patients, we collected bronchoalveolar lavage fluid less than 72 h after intubation and used Fourier Transform Infrared Spectroscopy to measure levels of dipalmitoylphosphatidylcholine (DPPC). A total of eleven COVID-19 patients with moderate-to-severe ARDS (CARDS) and 15 healthy controls were included. CARDS patients had lower DPPC levels than healthy controls. Moreover, a principal component analysis was able to separate patient groups into distinguishable subgroups. Our findings indicate markedly impaired pulmonary surfactant levels in COVID-19 patients, justifying further studies and clinical trials of exogenous surfactant.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pulmonary Surfactants / Bronchoalveolar Lavage Fluid / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Sci Rep Year: 2022 Document Type: Article Affiliation country: S41598-022-07944-4

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pulmonary Surfactants / Bronchoalveolar Lavage Fluid / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Sci Rep Year: 2022 Document Type: Article Affiliation country: S41598-022-07944-4